Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather ...

B, consensus $10.78B. Sees cash provided by operations $1.45B, and Capital expenditures $500M. For the Q1, the company now expects that worse-than-anticipated weather during the period will create a ...

This week, Quest Diagnostics made one of those deals. The diagnostics giant announced a new partnership with Google Cloud that aims to deliver new AI capabilities — including predictive ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Artificial Intelligence (AI) and Machine Learning (ML) play a pivotal role in precision oncology, analyzing vast datasets, ...

This was the stock's second consecutive day of losses.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate ...